1 almost-penny share that could rocket 203%, according to these pro analysts
Penny shares donât often draw the attention of professional analysts. And with these enterprises mostly too tiny for institutional investors, many promising businesses can end up being overlooked.
But that doesnât seem to be the case for Kooth (LSE:KOO). Following a double-digit surge in January, it’s now trading at a share price of around 119p â just slightly outside penny share territory.
The digital mental health platform has drawn the attention of the experts at Canaccord Genuity. And after evaluating the business, the team of analysts has placed its 12-month share price target at 330p. Thatâs a 203% projected potential gain â enough to turn £1,000 into over £3,000!
What’s made these experts so bullish? And should growth investors now rush to buy?
A 200% potential gain?
The surge in January was driven by a combination of factors. But what particularly stood out is the impressive progress being made in California. After signing a deal with the State Department of Health Care Services (DHCS), Kooth has outperformed its registration targets, with one in 40 young Californians signing up since its launch in January 2024.
While Koothâs US expansion is still in its early days, a successful scale-up of platform adoption across America presents a transformational opportunity for the business, unlocking a potential future surge in revenue. This is what has the team at Canaccord excited.
The California contract alone is estimated to add 145p of value per share for investors. And then combined with the cash on the balance sheet and value generated by the firmâs already-established UK operations, Canaccordâs sum-of-the-parts valuation model estimated the firmâs intrinsic value to be around 330p.
But when digging a little deeper, I spotted something troublingâ¦
Enormous margin of error
For Kooth shares to realise the hidden potential that Canaccord believes it’s identified, the firmâs expansion into California needs to be a success. So far, the registration numbers suggest that its mental health platform is resonating well. But that may ultimately not matter.
In October 2024, the State of Pennsylvania cancelled its contract with Kooth after an investigation revealed child safety concerns.
While politics may have had a role to play, the decision sets a precedent that might deter other states from engaging with the company for future contracts, as well as creating expansion headwinds in states where Kooth is already operating.
Even if that doesnât happen, the timeline of a full-scale ramp-up in the critical Californian market remains unknown. And subsequently, even the bullish projection from Canaccord reveals shrinking revenues in 2026 and 2027.
So where does that leave investors?
Whatâs the verdict?
Success in California is the critical catalyst needed for this near-penny share to unleash its growth potential. But as previously mentioned, it isn’t clear if and when this will happen.
In the meantime, the company is struggling to stay consistently profitable, rapidly burning through cash reserves, which shrank by 30% in the first six months of 2025 to £15m.
With that in mind, even though Canaccordâs investment thesis has merits, the outcome for Kooth appears to be binary. Either the share price will surge, or it will steadily collapse as cash runs out. And thatâs not a risk Iâm willing to take.
The post 1 almost-penny share that could rocket 203%, according to these pro analysts appeared first on The Motley Fool UK.
Should you invest £1,000 in Kooth Plc right now?
When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.
And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Kooth Plc made the list?
More reading
- Why UK stocks could be set to outperform
- Down 67% with a P/E of 7.8. Is this a once-in-a-decade chance to buy this downtrodden FTSE 250 stock?
- After rising 49%, are BP’s shares on course for £5.60?
- Greggs shares are at a 5-year low. Is this a chance to buy?
- Persimmon’s shares tank 14% in a week. With a yield of 4.6%, are they now a bargain?
Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
